StockData
NXGLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGLW

NEXGEL, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026
$5.80+0.21 (+3.76%)

Close on Oct 19, 2026

Market cap
$52.28M
P/E (TTM)
–
Dividend yield
–

NEXGEL, INC. revenue by segment

No segment breakdown reported

Nexgel does not break out revenue by segment, region or product in the tagged data of its filings for this period type.